Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1278-1282

  Stirban, Alin ^a,b   Kotsi, Paraskevi ^a   Franke, Knut ^c   Strijowski, Ulf ^c   Cai, Weijing ^d   GöTTING, Christian ^a   Tschoepe, Diethelm ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Profil Institute for Metabolic Research   (Germany)

^c German Institute of Food Technologies   (Germany)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; BETA LACTOGLOBULIN; NITRATE; NITRITE;

ADULT; AGED; ARTERY DILATATION; ARTICLE; BEVERAGE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIETARY INTAKE; ECHOGRAPHY; FLOW MEDIATED DILATATION; FOOD INTAKE; FOOD PROCESSING; HEAT TREATMENT; HUMAN; HYPEREMIA; LASER DOPPLER FLOWMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT;

ADULT; AGED; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LACTOGLOBULINS; MALE; MICROCIRCULATION; MIDDLE AGED;

EID: 84876798035     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1489     Document Type: Article

References (31)

1. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997;46(Suppl. 2):S19-S25 (Pubitemid 27377393)
2. Vlassara H, Palace MR. Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med 2003;70:232-241 (Pubitemid 37321701)
3. Nin JW, Jorsal A, Ferreira I, et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12-year follow-up study. Diabetes Care 2011;34:442-447
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820 (Pubitemid 34000785)
5. Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 2002;25: 1055-1059 (Pubitemid 41110493)
6. Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010;110:911-916, e12
7. Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002;99:15596-15601 (Pubitemid 35403978)
8. Uribarri J, Peppa M, Cai W, et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 2003;14:728-731 (Pubitemid 36246017)
9. Uribarri J, Peppa M, Cai W, et al. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis 2003;42:532-538 (Pubitemid 37048129)
10. Förster A, Ku€hne Y, Henle T. Studies on absorption and elimination of dietary maillard reaction products. Ann N Y Acad Sci 2005;1043:474-481 (Pubitemid 41123936)
11. Foerster A, Henle T. Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline. Bi-ochem Soc Trans 2003;31:1383-1385 (Pubitemid 38030981)
12. Erbersdobler HF, Faist V. Metabolic transit of Amadori products. Nahrung 2001;45:177-181 (Pubitemid 33626929)
13. Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 1997;94:6474-6479 (Pubitemid 27270709)
14. Negrean M, Stirban A, Stratmann B, et al. Effects of low-and high-advanced glyca-tion endproduct meals on macro-and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 2007; 85:1236-1243 (Pubitemid 46740464)
15. Uribarri J, Stirban A, Sander D, et al. Single oral challenge by advanced glyca-tion end products acutely impairs endo-thelial function in diabetic and nondiabetic subjects. Diabetes Care 2007;30:2579-2582 (Pubitemid 47547799)
16. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-1474 (Pubitemid 24344241)
17. Hadi HA, Carr CS, Al Suwaidi J. Endo-thelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 2005;1:183-198
18. Shimokawa H. Primary endothelial dysfunction: Atherosclerosis. J Mol Cell Car-diol 1999;31:23-37 (Pubitemid 29078216)
19. Ahmed N, Mirshekar-Syahkal B, Kennish L, Karachalias N, Babaei-Jadidi R, Thornalley PJ. Assay of advanced glycation end-products in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Mol Nutr Food Res 2005;49:691-699 (Pubitemid 41008207)
20. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothe-lial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340: 1111-1115
21. Birlouez-Aragon I, Saavedra G, Tessier FJ, et al. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 2010;91:1220-1226
22. Grau M, Hendgen-Cotta UB, Brouzos P, et al. Recent methodological advances in the analysis of nitrite in the human circulation: nitrite as a biochemical parameter of the L-arginine/NO pathway. J Chromatogr B Analyt Technol Biomed Life Sci 2007;851:106-123 (Pubitemid 46720145)
23. Seftel AD, Vaziri ND, Ni Z, et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or e NOS. Urology 1997;50:1016-1026 (Pubitemid 28021130)
24. Meigs JB, Hu FB, Rifai N, Manson JE. Bi-omarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-1986 (Pubitemid 38544279)
25. Stirban A, Negrean M, Stratmann B, et al. Benfotiamine prevents macro-and mi-crovascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006;29:2064-2071 (Pubitemid 44871188)
26. Kanabrocki EL, Murray D, Hermida RC, et al. Circadian variation in oxidative stress markers in healthy and type II di-abeticmen. Chronobiol Int 2002;19:423-439 (Pubitemid 34478037)
27. Blanco RA, Ziegler TR, Carlson BA, et al. Diurnal variation in glutathione and cys-teine redox states in human plasma. Am J Clin Nutr 2007;86:1016-1023 (Pubitemid 47538304)
28. Zhang H, Tasaka S, Shiraishi Y, et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008; 178:356-362
29. Buetler TM, Latado H, Leclerc E, et al. Glycolaldehyde-modified b-lactoglobulin AGEs are unable to stimulate inflammatory signaling pathways in RAGE-expressing human cell lines. Mol Nutr Food Res 2011;55:291-299
30. Inagawa H, Kohchi C, Soma G. Oral administration of lipopolysaccharides for the prevention of various diseases: benefit and usefulness. Anticancer Res 2011;31: 2431-2436
31. Sonaje K, Lin KJ, Tseng MT, et al. Effects of chitosan-nanoparticle- mediated tight junction opening on the oral absorption of endotoxins. Biomaterials 2011;32:8712-8721